BROOKE WALLING: Open Payments
NPI 1184234130 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 24 payments from 5 companies in 2025. Trend: 2023 $380 · 2024 $613 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $160 |
| Novo Nordisk Inc | 5 | $96 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| PFIZER INC. | 2 | $31 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: UBRELVY, QULIPTA, VRAYLAR, AIRSUPRA, Wegovy, Rybelsus, Ozempic, NURTEC ODT.
Industry payments across OK — which companies pay providers there.
